Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.
about
Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine.Challenges in vaccine therapy in hematological malignancies and strategies to overcome them.Modern strategies and capabilities for activation of the immune response against tumor cells.Enhanced synergistic anti-Lewis lung carcinoma effect of a DNA vaccine harboring a MUC1-VEGFR2 fusion gene used with GM-CSF as an adjuvant.Trial watch: DNA-based vaccines for oncological indications
P2860
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.
@en
type
label
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.
@en
prefLabel
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.
@en
P2860
P1476
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines
@en
P2093
Andrea Facciabene
John G Facciponte
P2860
P2888
P304
P356
10.1007/S00262-015-1747-8
P577
2015-08-13T00:00:00Z
P5875
P6179
1014744296